Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2022-04-01 2022-01-26
Drug Identification Number 02448610 02448610
Brand name BYDUREON BYDUREON
Common or Proper name exenatide for extended-release injectable suspension exenatide for extended-release injectable suspension
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients EXENATIDE EXENATIDE
Strength(s) 2MG 2MG
Dosage form(s) KIT POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT POWDER FOR SUSPENSION, EXTENDED-RELEASE
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 4 single dose pens 4 single dose pens
ATC code A10BJ A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-03-31 2022-03-31
Actual discontinuation date 2022-03-31 2022-03-31
Remaining supply date 2022-10-31 2022-10-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments